Mylan Antitrust Suit Over Mirapex Patent Sent To Del.
A federal judge in Pennsylvania has transferred to Delaware an antitrust suit brought by Mylan Inc. accusing Boehringer Ingelheim International GmbH of filing baseless litigation over a patent for Parkinson's drug...To view the full article, register now.
Already a subscriber? Click here to view full article